Tag: Patent Review

in Industrial Agricultural Biotech

Invented by Peter D. Harney, deceased, Vector Objects LLC The market for methods and kits for the preparation of multicomponent nucleic acids constructs has been growing rapidly in recent years. This is due to the increasing demand for more efficient and accurate methods of gene editing and gene therapy. Multicomponent nucleic acids constructs are complex…

Invention for Polynucleotides that encode antibodies against sclerostin, and their uses

—

by

Invented by Michaela Kniessel, Christine Halleux, Shou-Ih Hu, Beate Diefenbach-Streiber, Josef Prassler, MORPHYSYS AG, Mereo Biopharma 3 Ltd Polynucleotides that encode antibodies against sclerostin are becoming increasingly popular in the biopharmaceutical industry. Sclerostin is a protein that is primarily produced by osteocytes, which are cells that are responsible for bone formation and maintenance. Sclerostin inhibits…

Invention for Non-human mammal for the production chimeric antibodies

—

by

Invented by Larry Green, Hiroaki Shizuya, Ablexis LLC The market for non-human mammals for the production of chimeric antibodies is a rapidly growing industry. Chimeric antibodies are a type of monoclonal antibody that is created by combining the variable regions of a human antibody with the constant regions of an animal antibody. This process allows…

Invention for Blood-brain barrier antibodies

—

by

Invented by Eric V. Shusta, Angela R Jones, Charles C. Stutz, Wisconsin Alumni Research Foundation The blood-brain barrier (BBB) is a highly selective membrane that separates the circulating blood from the brain’s extracellular fluid. It is a critical component of the central nervous system, as it protects the brain from harmful substances while allowing essential…

Invention for Fc variants with modified binding to FcRn

—

by

Invented by Aaron Keith CHAMBERLAIN, Bassil Dahiyat, John R. Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Xencor Inc The market for Fc variants with modified binding to FcRn is rapidly growing due to their potential therapeutic benefits. FcRn is a receptor that plays a crucial role in the recycling and transport of immunoglobulin G (IgG)…

Invention for Cell-derived virus vaccines with low residual cell DNA

—

by

Invented by Jens-Peter Gregersen, Holger Kost, Seqirus UK Ltd The market for cell-derived virus vaccines with low residual cell DNA is rapidly growing due to the increasing demand for safe and effective vaccines. Cell-derived virus vaccines are produced using cell cultures, which are grown in bioreactors and then infected with the virus of interest. The…

Invention for Peptides, and combinations of peptides, for use in immunotherapy to treat epithelial cancers and other cancers.

—

by

Invented by Heiko Schuster, Janet PEPER, Philipp Wagner, Hans-Georg Rammensee, Immatics Biotechnologies GmbH Peptides are short chains of amino acids that play a crucial role in various biological processes. In recent years, peptides have gained significant attention in the field of immunotherapy for their potential to treat various types of cancers, including epithelial cancers. The…

Invention for Devices and systems for locating and interfacing with medication delivery systems

—

by

Invented by Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers, Streamline Studio Inc (f/k/a Ebap Inc D/b/a Streamline Design), kaleo Inc The market for devices and systems for locating and interfacing with medication delivery systems is rapidly growing. With the increasing demand for personalized healthcare, the need for efficient and effective…

Invention for Administration agents for the treatment

—

by